Curis, Inc. (CRIS)
0.4319
-0.04
(-7.99%)
USD |
NASDAQ |
Nov 20, 16:00
0.4319
0.00 (0.00%)
After-Hours: 19:15
Curis Gross Profit (TTM) : 1.076M for Sept. 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | 1.076M |
| June 30, 2026 | 4.215M |
| March 31, 2026 | 6.914M |
| December 31, 2025 | 9.229M |
| September 30, 2025 | 11.44M |
| June 30, 2025 | 11.16M |
| March 31, 2025 | 10.94M |
| December 31, 2024 | 10.25M |
| September 30, 2024 | 9.519M |
| June 30, 2024 | 9.381M |
| March 31, 2024 | 8.63M |
| December 31, 2023 | 8.894M |
| September 30, 2023 | 8.722M |
| June 30, 2023 | 8.403M |
| March 31, 2023 | 8.699M |
| December 31, 2022 | 8.514M |
| September 30, 2022 | 8.836M |
| June 30, 2022 | 9.088M |
| March 31, 2022 | 8.995M |
| December 31, 2021 | 9.13M |
| September 30, 2021 | 9.246M |
| June 30, 2021 | 9.21M |
| March 31, 2021 | 9.524M |
| December 31, 2020 | 10.10M |
| September 30, 2020 | 10.35M |
| Date | Value |
|---|---|
| June 30, 2020 | 10.43M |
| March 31, 2020 | 10.16M |
| December 31, 2019 | 9.376M |
| September 30, 2019 | 8.849M |
| June 30, 2019 | 8.821M |
| March 31, 2019 | 9.026M |
| December 31, 2018 | 9.688M |
| September 30, 2018 | 10.16M |
| June 30, 2018 | 9.759M |
| March 31, 2018 | 9.488M |
| December 31, 2017 | 9.167M |
| September 30, 2017 | 8.318M |
| June 30, 2017 | 7.675M |
| March 31, 2017 | 7.353M |
| December 31, 2016 | 6.991M |
| September 30, 2016 | 6.792M |
| June 30, 2016 | 7.107M |
| March 31, 2016 | 7.501M |
| December 31, 2015 | 7.473M |
| September 30, 2015 | 7.382M |
| June 30, 2015 | 7.129M |
| March 31, 2015 | 9.859M |
| December 31, 2014 | 9.504M |
| September 30, 2014 | 9.021M |
| June 30, 2014 | 14.46M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Lineage Cell Therapeutics, Inc. | 10.00M |
| Agenus, Inc. | 131.74M |
| Amgen, Inc. | 28.84B |
| Anika Therapeutics, Inc. | 78.26M |
| BioCryst Pharmaceuticals, Inc. | 938.98M |